GAIN THERAPEUTICS, INC Depreciation
GAIN THERAPEUTICS, INC (GANX) reported Depreciation of $15.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- GAIN THERAPEUTICS, INC depreciation for the quarter ending 2026-06-30 was $15.00K, a 50.00% increase year-over-year.
- GAIN THERAPEUTICS, INC depreciation for the quarter ending 2026-03-31 was $9.00K, a 0.00% change year-over-year.
- GAIN THERAPEUTICS, INC depreciation for the quarter ending 2025-12-31 was $16.00K, a 60.00% increase year-over-year.
- GAIN THERAPEUTICS, INC depreciation for the quarter ending 2025-09-30 was $10.00K, a 0.00% change year-over-year.
- GAIN THERAPEUTICS, INC depreciation for fiscal 2025 was $45.00K, a 18.42% increase from fiscal 2024.
- GAIN THERAPEUTICS, INC depreciation for fiscal 2024 was $38.00K, a 8.57% increase from fiscal 2023.
- GAIN THERAPEUTICS, INC depreciation for fiscal 2023 was $35.00K, a 31.42% increase from fiscal 2022.
- GAIN THERAPEUTICS, INC depreciation for fiscal 2022 was $26.63K, a 72.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.00K 10-Q · filed 2026-08-11 | $23.00K 10-Q · filed 2026-08-11 | $40.00K derived: sum of 3 quarters · filed 2026-08-11 | $50.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-11 | $25.00K derived: sum of 2 quarters · filed 2026-05-11 | $35.00K derived: sum of 3 quarters · filed 2026-05-11 | $45.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $26.00K derived: sum of 2 quarters · filed 2026-03-26 | $36.00K derived: sum of 3 quarters · filed 2026-08-11 | $45.00K 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-12 | $20.00K derived: sum of 2 quarters · filed 2026-08-11 | $29.00K 10-Q · filed 2025-11-12 | $39.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $10.00K 10-Q · filed 2026-08-11 | $19.00K 10-Q · filed 2026-08-11 | $29.00K derived: sum of 3 quarters · filed 2026-08-11 | $39.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-11 | $19.00K derived: sum of 2 quarters · filed 2026-05-11 | $29.00K derived: sum of 3 quarters · filed 2026-05-11 | $38.00K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $20.00K derived: sum of 2 quarters · filed 2026-03-26 | $29.00K derived: sum of 3 quarters · filed 2026-03-26 | $38.00K 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $10.00K 10-Q · filed 2025-11-12 | $19.00K derived: sum of 2 quarters · filed 2025-11-12 | $28.00K 10-Q · filed 2025-11-12 | $36.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $9.00K 10-Q · filed 2025-08-12 | $18.00K 10-Q · filed 2025-08-12 | $26.00K derived: sum of 3 quarters · filed 2025-08-12 | $35.00K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-14 | $17.00K derived: sum of 2 quarters · filed 2025-05-14 | $26.00K derived: sum of 3 quarters · filed 2025-05-14 | $43.14K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $18.00K derived: sum of 2 quarters · filed 2025-03-27 | $35.14K derived: sum of 3 quarters · filed 2025-03-27 | $35.00K 10-K · filed 2025-03-27 | $34.88K 10-K · filed 2024-03-26 | ||
| 2023-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $26.14K derived: sum of 2 quarters · filed 2024-11-14 | $26.00K 10-Q · filed 2024-11-14 | $26.05K 10-Q · filed 2023-11-14 | $41.91K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $17.14K 10-Q · filed 2023-08-10 | $17.00K 10-Q · filed 2024-08-08 | $32.91K derived: sum of 3 quarters · filed 2024-05-14 | $40.27K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2023-03-31 | $8.00K 10-Q · filed 2024-05-14 | $8.30K 10-Q · filed 2023-05-12 | $15.77K derived: sum of 2 quarters · filed 2024-05-14 | $23.13K derived: sum of 3 quarters · filed 2024-05-14 | $34.63K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $7.77K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $15.13K derived: sum of 2 quarters · filed 2024-03-26 | $26.63K derived: sum of 3 quarters · filed 2024-03-26 | $26.63K 10-K · filed 2024-03-26 | |||
| 2022-09-30 | $7.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $18.86K derived: sum of 2 quarters · filed 2023-11-14 | $18.86K 10-Q · filed 2023-11-14 | $29.95K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $11.50K 10-Q · filed 2023-08-10 | $11.50K 10-Q · filed 2022-08-08 | $22.59K derived: sum of 3 quarters · filed 2023-08-10 | $26.73K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $5.30K 10-Q · filed 2023-05-12 | $5.34K 10-Q · filed 2022-05-16 | $11.09K derived: sum of 2 quarters · filed 2023-05-12 | $15.22K derived: sum of 3 quarters · filed 2023-05-12 | $17.38K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $5.79K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.92K derived: sum of 2 quarters · filed 2023-03-23 | $12.08K derived: sum of 3 quarters · filed 2023-03-23 | $15.48K 10-K · filed 2023-03-23 | |||
| 2021-09-30 | $4.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $6.30K derived: sum of 2 quarters · filed 2022-11-10 | $9.70K 10-Q · filed 2022-11-10 | $9.70K 10-Q · filed 2021-11-12 | $12.53K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $2.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.56K 10-Q · filed 2022-08-08 | $8.39K derived: sum of 3 quarters · filed 2022-08-08 | $10.78K derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | $3.40K 10-Q · filed 2022-05-16 | $6.24K derived: sum of 2 quarters · filed 2022-05-16 | $8.62K derived: sum of 3 quarters · filed 2022-05-16 | $10.89K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $2.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $5.21K derived: sum of 2 quarters · filed 2022-03-25 | $7.49K derived: sum of 3 quarters · filed 2022-03-25 | $9.59K 10-K · filed 2022-03-25 | |||
| 2020-09-30 | $2.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $4.66K derived: sum of 2 quarters · filed 2021-11-12 | $6.76K 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $2.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.38K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $2.10K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |